FDA - Ristorantetavernettazogno

Fri. Dec 27th, 2024

Insights from long-term ASSURE data for Seladelpar

December 4, 2024 Amelia Journalton

While the treatment landscape for primary biliary cholangitis (PBC) has long been limited to just a handful of agents with limited efficacy, 2024 saw a major shift in PBC treatment…

News Update

Expedited approval of the use of new TKIs in CML Sparks issues

December 2, 2024 Amelia Journalton

US regulators’ use of a rapid release route for a new lead indication of asciminib in chronic myelogenous leukemia (CML) has raised questions due to the number of drugs already…